GSK

GlaxoSmithKline (GSK) distributed dividends in the last year,in the months of January, April, July and October totaling US$ 1,65. The Dividend Yield for the last 12 months is 3,74%.

Currently, GlaxoSmithKline (GSK) is priced at US$ 43,54, with a P/E of 13,33%, representing a deviation of 11,62% from its historical average P/E. In the last year, the stock showed a variation of 16.12% in its price and distributed US$ 1,65 in dividends, resulting in a Dividend Yield of 3,74%. The total shareholder return was 16,12%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Investing in stocks of GlaxoSmithKline (GSK) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

The yield of GlaxoSmithKline (GSK) was 8,69% in the last month, 16,12% in the last year and 82,43% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of US$ 1,65 in dividends, um Dividend Yield de 3,74%.

If you wanted to buy 100 stocks of GlaxoSmithKline (GSK) today, the total investment would be US$ 4.354,00, based on the current price of US$ 43,54.

If past performance were to repeat, the return on your investment would be:

• In 1 year: US$ 5.055,86
• In 5 years: US$ 7.943,00
• In 10 years: 10.359,91

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.